Skip to main content
Gregory Vercellotti, MD, Oncology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

GregoryMVercellottiMD

Oncology • Minneapolis, MN

Hematologic Oncology

University of Minnesota Physicians

Join to view full profile

Dr. Vercellotti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Vercellotti's full profile

Already have an account?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Hematology and Medical Oncology, 1979 - 1982
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1976 - 1979
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1976

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1979 - 2024
  • WI State Medical License
    WI State Medical License 1977 - 1978
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Elected Member The American Society for Clinical Investigation, 1993
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Association between Sensorineural Hearing Loss and Homozygous Sickle Cell Anemia: A Meta-Analysis
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Increased Release of Soluble MD-2 in Sickle Cell Disease and Its Role in Pro-Inflammatory Signaling in Endothelial Cells
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Identification of a Heme Activation Site on the MD-2/TLR4 Complex
    Gregory M Vercellotti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Facilitating Resolution of Life-Threatening Acute Graft-Versus-Host Disease By Supplementation of Human Chorionic Gonadotropin and Epidermal Growth Factor (Pregnyl): A... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Sickle Cell Trait, Disease Linked with Faster Kidney Function Decline in African American Patients
    Sickle Cell Trait, Disease Linked with Faster Kidney Function Decline in African American PatientsFebruary 17th, 2020
  • University of Michigan Medical Student Earns Spot in 2019 ASH Minority Medical Student Award Program
    University of Michigan Medical Student Earns Spot in 2019 ASH Minority Medical Student Award ProgramSeptember 16th, 2019

Grant Support

  • Hematology Research Training ProgramNational Heart, Lung, And Blood Institute2008–2011
  • Heme Oxygenase 1 &StasisNational Heart, Lung, And Blood Institute2007–2011
  • Cell CultureNational Heart, Lung, And Blood Institute2007–2011
  • Inflammation In Sickle DiseaseNational Heart, Lung, And Blood Institute2001–2007
  • Core--Tissue CultureNational Heart, Lung, And Blood Institute1996–2002
  • Neutrophil/Endothelial Cell CommunicationNational Heart, Lung, And Blood Institute1990–1993
  • Mechanisms Of Neutrophil-Mediated Tissue DamageNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1989
  • Effect Of Pmn-Derived Oxidants On Pmn/Platelet FunctionNational Heart, Lung, And Blood Institute1986–1988
  • Mechanisms Of Neutrophil-Mediated Tissue DamageNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985

Hospital Affiliations

Dr. Gregory Vercellotti, Dr. Gregory Vercellotti, MD, Dr. G Vercellotti, Dr. Gregory M Vercellotti